Collectively, these findings establish that mutant FAT1 drives CPT1A‐dependent FAO, facilitating a metabolic bypass that confers resistance to TCA cycle inhibition in HNSCC. The gene discussed is CPT1A; the disease is head and neck squamous cell carcinoma.